TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25373630

Group type: EXPERIMENTAL
Intervention: Intranasal rapid-acting insulin glulisine
Number of subjects: 9
Study: 23287844

Group type: EXPERIMENTAL
Intervention: Daily diaries (asthma control days - ACDs)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Retrospective questionnaires (Asthma Control Test - ACT)
Number of subjects: 182
Study: 20094068

Group type: EXPERIMENTAL
Intervention: 6-0 Prolene suture (group 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 10-0 Prolene suture (group 2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cox regression analysis
Number of subjects: 90
Study: 18221838

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (20 IU)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17198210

Group type: EXPERIMENTAL
Intervention: Single-dose oral dexamethasone (0.6 mg/kg to a maximum of 18 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 days of twice-daily prednisolone (1 mg/kg per dose to a maximum of 30 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose oral dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 days of twice-daily prednisolone
Number of subjects: 0
Study: 14572560

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (QT)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Dual therapy (DT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Omeprazole and placebo therapy (OPl)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: H. pylori negative patients
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: H. pylori positive patients
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: H. pylori positive and negative patients
Number of subjects: 223
Study: 10934074

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 8921924

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) at a mean dose of 2.7 +/- 1.1 mg/kg/day (n = 15)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Chloroquine (Chl) at a dose of 100 mg/day (n = 11)
Number of subjects: 44
Study: 1633284

Group type: EXPERIMENTAL
Intervention: Positron emission tomography with H2(15)O injection
Number of subjects: 0
Study: 2951011

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 56

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 56
Study: 29345011

Group type: EXPERIMENTAL
Intervention: Multimethod venous thromboembolism prevention education plan (video, pamphlet, verbal instruction)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual instructional pamphlet
Number of subjects: 66
Study: 27982389

Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 24606847

Group type: EXPERIMENTAL
Intervention: Active Breathing Coordinator (ABC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No Active Breathing Coordinator (No-ABC)
Number of subjects: 43
Study: 26856040

Group type: EXPERIMENTAL
Intervention: HIV-infected children
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: HIV-uninfected children
Number of subjects: 875
Study: 20177839

Group type: EXPERIMENTAL
Intervention: 10-mm laterally wedged insole
Number of subjects: 91

Group type: COMPARATOR
Intervention: Valgus brace
Number of subjects: 91
Study: 18318925

Group type: EXPERIMENTAL
Intervention: 12-lead event recorder and telemedicine call centre access
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1500
Study: 16029791

Group type: COMPARATOR
Intervention: Radiotherapy alone (59.4 Gy external beam radiotherapy in 1.8 Gy fractions)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Radiotherapy with 5-FU (1,000 mg/m2/day for 4 days by continuous infusion Days 2-5 and 28-31) and MMC (10 mg/m2 on Day 2)
Number of subjects: 114
Study: 12885977

Group type: EXPERIMENTAL
Intervention: Oral prednisolone 0.6 mg/kg for 14 days
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Confirmed ex-smokers
Number of subjects: 524

Group type: COMPARATOR
Intervention: Placebo or fluticasone propionate treatment
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Prednisolone response
Number of subjects: 524
Study: 10589440

Group type: EXPERIMENTAL
Intervention: Balm mint cream (1% Lo-701) applied topically four times daily for five days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo cream applied topically four times daily for five days
Number of subjects: 66
Study: 7546806

Group type: EXPERIMENTAL
Intervention: Cefuroxime (CFX)
Number of subjects: 385

Group type: COMPARATOR
Intervention: Cefazolin (CFZ)
Number of subjects: 385
Study: 1778138

Group type: EXPERIMENTAL
Intervention: Flumazenil (1 mg)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 7008825

Group type: EXPERIMENTAL
Intervention: Norethisterone oenanthate (NET‐OEN)
Number of subjects: 1678

Group type: COMPARATOR
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 1678
Study: 31780142

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Direct invasive coronary angiography (ICA)
Number of subjects: 120
Study: 31122656

Group type: EXPERIMENTAL
Intervention: Supervised combined intermittent aerobic, muscle strength and home-based walking training programs
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 29202863

Group type: EXPERIMENTAL
Intervention: Family Dignity Intervention (FDI) offered in addition to standard psychological care
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard psychological care
Number of subjects: 126
Study: 26613136

Group type: EXPERIMENTAL
Intervention: Columbia Suicide Severity Rating Scale (C‐SSRS)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Suicide Tracking Scale (STS)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Sheehan Suicidality Tracking Scale (S‐STS)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Interrater agreement
Number of subjects: 199
Study: 25039403

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 148

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 148
Study: 22939807

Group type: EXPERIMENTAL
Intervention: Right ventricular apex pacing
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Interventricular septum pacing
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Interventricular septum pacing with anterior RV lead position
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Interventricular septum pacing with mid-septal lead position
Number of subjects: 59

Group type: COMPARATOR
Intervention: Right ventricular pacing (both groups)
Number of subjects: 59
Study: 19204845

Group type: EXPERIMENTAL
Intervention: Transparent hydrogel pad
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fluid gel
Number of subjects: 21
Study: 17043681

Group type: EXPERIMENTAL
Intervention: Methenamine Hippurate (MH) 1 g twice-daily
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Cranberry tablets 800 mg twice-daily
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 15182771

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 11583639

Group type: EXPERIMENTAL
Intervention: Oral antimicrobials
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Early-switch therapy
Number of subjects: 188

Group type: COMPARATOR
Intervention: Parenteral antimicrobials
Number of subjects: 188

Group type: COMPARATOR
Intervention: Full course of parenteral antibiotics
Number of subjects: 188
Study: 10886696

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 14

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 14
Study: 8993086

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 33
Study: 1319873

Group type: EXPERIMENTAL
Intervention: Temafloxacin 800mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxacin 800mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxacin-theophylline administration
Number of subjects: 12
Study: 6383512

Group type: EXPERIMENTAL
Intervention: Angelchik prosthesis
Number of subjects: 52

Group type: COMPARATOR
Intervention: Fundoplication
Number of subjects: 52
Study: 30624719

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 21028

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21028

Group type: COMPARATOR
Intervention: Edoxaban vs. Warfarin
Number of subjects: 21028
Study: 29967368

Group type: EXPERIMENTAL
Intervention: NFE (upregulation of emotion areas)
Number of subjects: 43

Group type: COMPARATOR
Intervention: NFS (upregulation of a control region activated by visual scenes)
Number of subjects: 43
Study: 26841217

Group type: EXPERIMENTAL
Intervention: Lifestyle Advice (comprehensive dietary and lifestyle intervention over the course of pregnancy including dietary, exercise and behavioural strategies, delivered by a research dietician and research assistants)
Number of subjects: 970

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 970
Study: 24506318

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23082385

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 20609851

Group type: EXPERIMENTAL
Intervention: Parental motivational beliefs (role construction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parental motivational beliefs (efficacy)
Number of subjects: 0
Study: 18501068

Group type: EXPERIMENTAL
Intervention: Capecitabine in conjunction with radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) based chemotherapy
Number of subjects: 0
Study: 15643914

Group type: EXPERIMENTAL
Intervention: Social skills intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 45
Study: 12794466

Group type: EXPERIMENTAL
Intervention: Flap skin donor site (group I)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Posterolateral thigh donor site (group II)
Number of subjects: 38
Study: 10492099

Group type: EXPERIMENTAL
Intervention: Antenatal TRH 400 microg every eight hours for four doses
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Antenatal TRH
Number of subjects: 225
Study: 8601364

Group type: EXPERIMENTAL
Intervention: 500 mg ursodeoxycholic acid (UDCA) per day (N = 14)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin per day (N = 14)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Diet (N = 15)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No treatment (Control, N = 15)
Number of subjects: 58
Study: 1902253

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methohexital
Number of subjects: 0
Study: 30991248

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) at a dosage of 2400 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 29898192

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT), 16 sessions
Number of subjects: 0
Study: 26778719

Group type: EXPERIMENTAL
Intervention: 3-Hz ipsilesional rTMS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1-Hz contralesional rTMS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3-Hz rTMS
Number of subjects: 40
Study: 24636501

Group type: EXPERIMENTAL
Intervention: Self-compassion training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention (placebo) control
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 0
Study: 22490391

Group type: EXPERIMENTAL
Intervention: BioP-plus
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PXL-8
Number of subjects: 100
Study: 19845788

Group type: EXPERIMENTAL
Intervention: True manipulation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 18035796

Group type: EXPERIMENTAL
Intervention: CFC-driven MDI
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: non-CFC (HFA) MDI
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: salbutamol dry powder inhaler (DPI)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Overall comparison of inhalers
Number of subjects: 419
Study: 16135832

Group type: EXPERIMENTAL
Intervention: Ringer's lactate
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: 6 percent dextran 70 (a colloid)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: 6 percent hydroxyethyl starch (a colloid)
Number of subjects: 512

Group type: COMPARATOR
Intervention: All fluid-treatment groups
Number of subjects: 512
Study: 11806986

Group type: EXPERIMENTAL
Intervention: Filgrastim 10 microg/kg subcutaneous daily for 5 days
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Filgrastim mobilization
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PBSCs collected from SCT
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cryopreservation in 5% dimethyl sulfoxide/6% pentastarch
Number of subjects: 8
Study: 10430523

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (30 mg/kg body weight i.v.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no methylprednisolone)
Number of subjects: 50
Study: 7589378

Group type: EXPERIMENTAL
Intervention: Short-term inhaled corticosteroids (200 micrograms b.i.d.) for 4 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Long-term inhaled corticosteroids (100-1000 micrograms b.i.d.) for less than 6 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 32
Study: 1981784

Group type: EXPERIMENTAL
Intervention: Urine collected overnight, corrected for creatinine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Urine collected overnight, expressed as microgram albumin/mg creatinine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Urine samples collected overnight, corrected for creatinine
Number of subjects: 32
Study: 7298846

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid (CDC) 750 mg/d
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid (CDC) 375 mg/d
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 31625952

Group type: EXPERIMENTAL
Intervention: Web-based education (n=33)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (treatment as usual, n=24)
Number of subjects: 57
Study: 28685960

Group type: EXPERIMENTAL
Intervention: Stem Cell Educator (SCE) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCE therapy
Number of subjects: 0
Study: 27097857

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg intranasal midazolam sedation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg sublingual midazolam sedation
Number of subjects: 40
Study: 24313543

Group type: EXPERIMENTAL
Intervention: Customised dietary intervention (increased consumption of fruits, vegetables, and whole grains)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Customised dietary intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (normal clinical treatment without customised dietary advice)
Number of subjects: 51
Study: 22327053

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with larger month-to-month weight losses in year 1
Number of subjects: 2438

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with sustained weight loss during the first year
Number of subjects: 2438

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with larger monthly weight loss during year 1
Number of subjects: 2438
Study: 19534616

Group type: EXPERIMENTAL
Intervention: Slow-breathing exercises
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fast-breathing exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 16855765

Group type: EXPERIMENTAL
Intervention: 20 mg of tadalafil taken as needed (maximum once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12697798

Group type: EXPERIMENTAL
Intervention: External hip protector
Number of subjects: 561

Group type: COMPARATOR
Intervention: Control group (no hip protector)
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: External hip protector (compliant participants)
Number of subjects: 561
Study: 10805064

Group type: EXPERIMENTAL
Intervention: Methoxsalen (CYP2A6 inhibitor)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Troleandomycin (CYP3A4 inhibitor)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no inhibitor)
Number of subjects: 27
Study: 8877655

Group type: EXPERIMENTAL
Intervention: 2% minocycline hydrochloride-gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo-gel
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% minocycline hydrochloride-gel and Placebo-gel
Number of subjects: 20
Study: 1817947

Group type: EXPERIMENTAL
Intervention: Preventive care program (information on oral hygiene, fluoridation and healthy nutrition, instructions and training) in group 1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Use of fluoride tablets for babies planned by group 1
Number of subjects: 200

Group type: COMPARATOR
Intervention: Use of fluoride tablets for babies planned by group 2
Number of subjects: 200
Study: 6407598

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation as aspartate hydrochloride 15 mmol/day for six months
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 20
Study: 31242936

Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF) on post-operative day 1 (POD1)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Delayed oral feeding (DOF) on post-operative day 4 (POD4)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: EOF group
Number of subjects: 200

Group type: COMPARATOR
Intervention: DOF group
Number of subjects: 200
Study: 29025481

Group type: EXPERIMENTAL
Intervention: Respondent's external stigma (RES) scale
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Others' external stigma (OES) scale
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: All four stigma scales
Number of subjects: 882
Study: 25420946

Group type: EXPERIMENTAL
Intervention: Community pharmacist-delivered diabetes support program (5 months, 5 follow-up visits, 5 phone calls)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Community pharmacist-delivered diabetes support program
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 101
Study: 23435801

Group type: EXPERIMENTAL
Intervention: HRV biofeedback (BIO)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparative group (COM)
Number of subjects: 18
Study: 22046722

Group type: EXPERIMENTAL
Intervention: virtual-physical fidelity training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cognitive fidelity training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: real-world training
Number of subjects: 0

Group type: COMPARATOR
Intervention: control group
Number of subjects: 0
Study: 19277796

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics for 2 days followed by oral antibiotics for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Surgery (control group)
Number of subjects: 80
Study: 16420755

Group type: EXPERIMENTAL
Intervention: PEG‐IFNalpha‐2a
Number of subjects: 60

Group type: COMPARATOR
Intervention: CIFNalpha‐2a
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PEG‐IFNalpha‐2a (genotype 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CIFNalpha‐2a (genotype 1)
Number of subjects: 60
Study: 15785008

Group type: EXPERIMENTAL
Intervention: Green coffee bean extract (GCE) 140 mg/day for 4 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo drink for 4 months
Number of subjects: 20
Study: 11320110

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (nonexercise)
Number of subjects: 7
Study: 10209405

Group type: EXPERIMENTAL
Intervention: Atkinson tubes
Number of subjects: 87

Group type: COMPARATOR
Intervention: Self-expanding metal stents
Number of subjects: 87
Study: 8165852

Group type: EXPERIMENTAL
Intervention: DTPa with 25 micrograms PT
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: DTPa with 8 micrograms PT
Number of subjects: 308

Group type: COMPARATOR
Intervention: DTPw (whole-cell pertussis DTP vaccine)
Number of subjects: 308
Study: 3421452

Group type: EXPERIMENTAL
Intervention: Fibreoptic intubation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Macintosh laryngoscope intubation
Number of subjects: 0
Study: 28418191

Group type: EXPERIMENTAL
Intervention: Jinlida
Number of subjects: 192
Study: 26656958

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Multiple daily injections with glargine (MDI/G)
Number of subjects: 45
Study: 26333503

Group type: EXPERIMENTAL
Intervention: Low concentration of contrast agent (270 mgI/mL of iodixanol)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: High concentration of contrast agent (320 mgI/mL of iodixanol)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Scan condition A (120 kV, 300 mA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Scan condition B (100 kV, 400 mA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Scan condition C (100 kV, 300 mA)
Number of subjects: 180
Study: 23439163

Group type: EXPERIMENTAL
Intervention: Gap-filling approach for continuous glucose monitoring (CGM) data
Number of subjects: 0